Patent 11919925 was granted and assigned to Alexion Pharmaceuticals on March, 2024 by the United States Patent and Trademark Office.
Provided herein are methods of performing viral filtration on a fluid including a recombinant antibody, and the use of these methods in methods of manufacturing or producing the recombinant antibody.